MedPath

COVID-19 Vaccine Messaging, Part 1

Not Applicable
Completed
Conditions
COVID-19
Vaccination
Interventions
Other: Control message
Other: Baseline message
Other: Personal freedom message
Other: Community interest message
Other: Anger message
Other: Self-interest message
Other: Economic benefit message
Other: Guilt message
Other: Embarrassment message
Other: Economic freedom message
Other: Trust in science message
Other: Not bravery message
Registration Number
NCT04460703
Lead Sponsor
Yale University
Brief Summary

This study tests different messages about vaccinating against COVID-19 once the vaccine becomes available. Participants are randomized to 1 of 12 arms, with one control arm and one baseline arm. We will compare the reported willingness to get a COVID-19 vaccine at 3 and 6 months of it becoming available between the 10 intervention arms to the 2 control arms.

Study participants are recruited online by Lucid, which matches census based sampling in online recruitment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
4000
Inclusion Criteria
  • At least 18 years of age
  • US resident
Read More
Exclusion Criteria
  • Younger than 18 years of age
  • Non-US resident
  • Do not consent
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ControlControl messageControl message about birdfeeding
Baseline messageBaseline messageThese participants will be assigned a message about the benefits of vaccination. All other treatment arms include this baseline language.
Personal freedomPersonal freedom messageExperimental message arm.
Social benefit, community interestCommunity interest messageExperimental message arm.
Social pressure- angerAnger messageExperimental message arm.
Social benefit, self-interestSelf-interest messageExperimental message arm.
Economic benefitEconomic benefit messageExperimental message arm.
Social pressure- guiltGuilt messageExperimental message arm.
Social pressure- embarrassmentEmbarrassment messageExperimental message arm.
Economic freedomEconomic freedom messageExperimental message arm.
Trust in scienceTrust in science messageExperimental message arm.
Not bravery armNot bravery messageExperimental message arm.
Primary Outcome Measures
NameTimeMethod
Intention to get COVID-19 vaccineImmediately after intervention, in the same survey in which the intervention message is provided

This is a self reported measure, immediately after the intervention message, of the likelihood of getting a COVID-19 vaccination within 3 months and then 6 months of it becoming available. During analysis, responses among those assigned to different intervention messages will be compared to those in the control group.

Secondary Outcome Measures
NameTimeMethod
Persuade others itemImmediately after intervention, in the same survey in which the intervention message is provided

This is a measure of a willingness to persuade others to take the COVID-19 vaccine.

Fear of those who have not been vaccinatedImmediately after intervention, in the same survey in which the intervention message is provided

This is a measure of a comfort with an unvaccinated individual visiting an elderly friend after a vaccine becomes available

Vaccine confidence scaleImmediately after intervention, in the same survey in which the intervention message is provided

This is a validated scale. This scale will be used to assess the impact of the messages on vaccine confidence. (Outcome assessed only for the half of the sample that answers these items post-treatment)

Social judgment of those who do not vaccinateImmediately after intervention, in the same survey in which the intervention message is provided

This is a scale composed of 4 items measuring the trustworthiness, selfishness, likeableness, and competence of those who choose not to get vaccinated after a vaccine becomes available

Trial Locations

Locations (1)

Yale University

πŸ‡ΊπŸ‡Έ

New Haven, Connecticut, United States

Β© Copyright 2025. All Rights Reserved by MedPath